Skip to content
My WebMD Sign In, Sign Up
Font Size
A
A
A

New Type of Prostate Cancer Pill Extends Lives

Men Given MDV3100 Live an Average of Nearly 5 Months Longer

Drug Well-Tolerated continued...

What is really exciting, Roth tells WebMD, is the prospect that the once-a-day treatment might be able to be used earlier in the course of disease, thereby delaying the time until men need chemotherapy. That is being tested in a large study now.

Also at the news briefing, researchers reported that an experimental radiation-emitting agent that targets bone both extended survival and delayed cancer-related bone problems in men with late-stage spreading prostate cancer.

The intravenous drug, known as Alpharadin, is undergoing FDA review. Roth says that since MDV3100 and Alpharadin work in different ways, they might work well in combination. No price has been set for either drug.

These findings were presented at a medical conference. They should be considered preliminary as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.

1 | 2

Today on WebMD

Prostate Cancer Overview
SLIDESHOW
what is your cancer risk
HEALTH CHECK
 
Prostate Exam
VIDEO
Prostate Nerve Transplant
VIDEO
 
cancer fighting foods
SLIDESHOW
15 Cancer Symptoms Men Ignore
FEATURE
 
Prostate Enlarged
VIDEO
Picture Of The Prostate
ANATOMY
 
Prostate Cancer Quiz
QUIZ
screening tests for men
SLIDESHOW
 
Prostate Cancer Symptoms
VIDEO
Vitamin D
SLIDESHOW